UnitedHealth Group Incorporated (UNH) Holdings Cut by Reliance Trust Co. of Delaware

Reliance Trust Co. of Delaware lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,877 shares of the healthcare conglomerate’s stock after selling 1,184 shares during the period. UnitedHealth Group makes up about 1.1% of Reliance Trust Co. of Delaware’s investment portfolio, making the stock its 12th biggest position. Reliance Trust Co. of Delaware’s holdings in UnitedHealth Group were worth $7,026,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Marshall Wace LLP grew its holdings in shares of UnitedHealth Group by 441.4% in the 2nd quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock worth $2,578,000 after acquiring an additional 11,361 shares during the period. American Century Companies Inc. grew its holdings in shares of UnitedHealth Group by 16.9% in the 2nd quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after acquiring an additional 681,111 shares during the period. Schwab Charles Investment Management Inc. grew its holdings in shares of UnitedHealth Group by 5.3% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock worth $678,077,000 after acquiring an additional 183,401 shares during the period. Essex Financial Services Inc. grew its holdings in shares of UnitedHealth Group by 12.3% in the 2nd quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock worth $1,640,000 after acquiring an additional 967 shares during the period. Finally, Factory Mutual Insurance Co. grew its holdings in UnitedHealth Group by 20.9% during the 2nd quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock valued at $77,245,000 after buying an additional 72,000 shares during the last quarter. Institutional investors and hedge funds own 85.97% of the company’s stock.

UnitedHealth Group Incorporated (NYSE:UNH) opened at $221.69 on Friday. UnitedHealth Group Incorporated has a 52 week low of $156.09 and a 52 week high of $231.77. The firm has a market capitalization of $215,501.23, a price-to-earnings ratio of 23.17, a price-to-earnings-growth ratio of 1.65 and a beta of 0.66. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. During the same quarter in the prior year, the company posted $2.17 EPS. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. sell-side analysts expect that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st were paid a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date was Thursday, November 30th. UnitedHealth Group’s dividend payout ratio is presently 33.26%.

UNH has been the topic of a number of analyst reports. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. Cantor Fitzgerald reiterated a “buy” rating and set a $225.00 target price on shares of UnitedHealth Group in a report on Monday, November 27th. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Piper Jaffray Companies increased their target price on UnitedHealth Group to $228.00 and gave the company an “overweight” rating in a report on Tuesday, October 17th. Finally, Jefferies Group reiterated a “buy” rating and set a $248.00 target price on shares of UnitedHealth Group in a report on Friday, December 1st. Three equities research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $224.56.

In related news, CEO Larry C. Renfro sold 22,598 shares of the stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Thomas E. Roos sold 975 shares of the stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the transaction, the insider now directly owns 24,630 shares in the company, valued at $5,060,726.10. The disclosure for this sale can be found here. In the last three months, insiders have sold 34,630 shares of company stock worth $7,669,416. Corporate insiders own 0.89% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was first posted by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another site, it was stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this story can be read at https://www.com-unik.info/2017/12/22/unitedhealth-group-incorporated-unh-holdings-cut-by-reliance-trust-co-of-delaware.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit